DM Clinical Research at Tomball

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Rheumatoid arthritis2 trials

Phase

• Phase 22 trials

Status

• Recruiting2 trials

Lead sponsor

• Hoffmann-La Roche2 trials

Running trials

• Recruiting

  An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis

  NCT07620392· Phase 2· Hoffmann-La Roche· Source

• Recruiting

  A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

  NCT07137598· Phase 2· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Rheumatoid arthritis2 recruiting